April 5, 2023

The U.S. Food and Drug Administration (FDA) released draft guidance — Marketing Submission Recommendations for a Predetermined Change Control Plan (PCCP) for Artificial Intelligence/Machine Learning (AI/ML)-Enabled Device Software Functions — with public comments due July 3.

The document describes information provided by manufacturers that would enable FDA consideration of planned AI/ML software modifications during device marketing submissions. The PCCP enables downstream improvements to AI/ML software functionality without necessitating additional submissions, provided the future modifications are implemented in accordance with the FDA-vetted plan.

The American College of Radiology® (ACR®) is reviewing the draft guidance. Members interested in providing feedback for potential inclusion in ACR’s future comments should contact Michael Peters, ACR Senior Government Affairs Director.


Related ACR News

  • ACR 2025 Economics Forum

    The Economics Forum at ACR 2025 highlighted recent successes including coverage of CT colonoscopy for Medicare patients and new CPT codes for MRI safety.

    Read more
  • Radiology Advocacy Begins Now

    Medical student, Annie Pham, BS, M3 of Edward Via College of Osteopathic Medicine, Louisiana Campus, discusses her experiences during the 2025 ACR Capitol Hill Day.

    Read more
  • Connections Through Advocacy: Familiar Faces Along the Interview Trail

    Read more